UNC Lineberger Comprehensive Cancer Center: Carcinoma, Non-Small-Cell Lung trials

The registry lists 13 Carcinoma, Non-Small-Cell Lung studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 2 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 3Phase 2 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Infusion Timing on Treatment Response in Solid TumorsRecruitingNCT07630168Phase 2
• Autologous CAR T-Cells Targeting the GD2 Antigen for Lung CancerRecruitingNCT05620342Early Phase 1
• Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxelCompletedNCT02684461Phase 2Results posted
• Cisplatin and Nab-paclitaxel for (N2) Defined NSCLCTerminatedNCT02276560Phase 2Results posted
• Single Arm on the Tolerability of Weekly Nab-paclitaxelCompletedNCT01702844Phase 2Results posted
• Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)CompletedNCT01573702Phase 2Results posted
• Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung CancerTerminatedNCT00280748Phase 2Results posted
• Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00280150Phase 1/2Results posted
• Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLCSuspendedNCT07639242Phase 2
• Abequolixron (RGX-104) and Durvalumab in Lung CancerTerminatedNCT05911308Phase 1
• Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) SubjectsCompletedNCT01323062Phase 1
• Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With ChemotherapyWithdrawnNCT00998101Phase 2
• Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2